NCT01607216View on ClinicalTrials.gov

Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies

CompletedOBSERVATIONAL
Enrollment

277

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
PrematuritySymptomatic Respiratory DiseaseBronchopulmonary Dysplasia
Trial Locations (2)

14222

Women and Children's Hospital of Buffalo, Buffalo

14642

University of Rochester Medical Center, Rochester

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

University at Buffalo

OTHER

lead

University of Rochester

OTHER

NCT01607216 - Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies | Biotech Hunter | Biotech Hunter